168 related articles for article (PubMed ID: 7002675)
21. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
22. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
[TBL] [Abstract][Full Text] [Related]
23. Immunogenetic heterogeneity in type I (insulin-dependent) diabetes among the Tunisian population. HLA-DR antigens and organ-specific autoantibodies (family study).
Jenhani F; Bardi R; Chammakhi S; Jeddi M; Ayed K
J Autoimmun; 1991 Jun; 4(3):553-61. PubMed ID: 1910427
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
25. Genetic and immunological markers of insulin dependent diabetes in Black Americans.
Leech NJ; Kitabchi AE; Gaur LK; Hagopian WA; Hansen J; Burghen GA; Palmer JP; Nepom GT
Autoimmunity; 1995; 22(1):27-32. PubMed ID: 8882419
[TBL] [Abstract][Full Text] [Related]
26. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
Gerling I; Baekkeskov S; Lernmark A
J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
28. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
29. Islet cell antibodies in patients with autoimmune thyroid disease.
Yamaguchi Y; Chikuba N; Ueda Y; Yamamoto H; Yamasaki H; Nakanishi T; Akazawa S; Nagataki S
Diabetes; 1991 Mar; 40(3):319-22. PubMed ID: 1999272
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
31. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.
Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y
Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550
[TBL] [Abstract][Full Text] [Related]
32. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
33. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
[TBL] [Abstract][Full Text] [Related]
34. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
35. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
36. ICA and organ-specific autoantibodies among Japanese patients with early-onset insulin-dependent diabetes mellitus--the JDS study.
Kida K; Mimura G; Kobayashi T; Matsuura N; Toyota T; Kitagawa T; Hibi I; Ikeda Y; Tuchida I; Kuzuya H
Diabetes Res Clin Pract; 1994 Apr; 23(3):187-93. PubMed ID: 7924880
[TBL] [Abstract][Full Text] [Related]
37. Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.
Bottazzo GF; Genovese S; Bosi E; Dean BM; Christie MR; Bonifacio E
Ann Med; 1991 Oct; 23(4):453-61. PubMed ID: 1930942
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
[TBL] [Abstract][Full Text] [Related]
39. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
40. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden.
Landin-Olsson M; Karlsson FA; Lernmark A; Sundkvist G
Diabetes; 1992 Aug; 41(8):1022-7. PubMed ID: 1628762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
